Integer Holdings Corporation (ITGR) Stock Analysis
Healthcare · Medical Devices · NYSE
Integer Holdings Corporation (ITGR) posted $1.85B in revenue for fiscal 2025 (up 8.0% year over year), at a 5.5% net margin, and has compounded revenue about 11.5%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on Integer Holdings Corporation
Integer Holdings Corporation has grown revenue from $1.08B to $1.85B over the last 10 fiscal years, compounding about 11.5% a year. The most recent year was up 8%, so growth has cooled from its longer-run pace.
Net margin sits at 5.5%, down 1.5 points year over year on a 27% gross margin. It carries about $1.19B of total debt.
At today's valuation the market is pricing in roughly 13.1% annual free-cash-flow growth — versus the -4.8% it actually delivered over the last five years, so the price already assumes a step-up from the recent record. The one thing worth a second look in the filings is receivables growing faster than sales.
Synthesised from Integer Holdings Corporation's SEC filings — descriptive, not advice. Ask the analyst your own question →
Integer Holdings Corporation revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.08B | $1.14B | $1.22B | $1.26B | $1.07B | $1.22B | $1.38B | $1.60B | $1.72B | $1.85B |
| Gross profit | $337.68M | $354.01M | $362.67M | $355.01M | $285.71M | $336.97M | $345.76M | $409.89M | $459.01M | $500.39M |
| Net income | $5.96M | $66.68M | $167.96M | $96.34M | $77.26M | $96.81M | $66.38M | $90.65M | $119.90M | $102.81M |
| Net margin | 0.6% | 5.9% | 13.8% | 7.7% | 7.2% | 7.9% | 4.8% | 5.7% | 7.0% | 5.5% |
Source: Integer Holdings Corporation SEC filings (10-K). 17 years of history available in the interactive view.
Integer Holdings Corporation: 2 potential red flags in the filings
Patterns in the filed statements worth a second look — computed and cited, not AI guesswork, and not a signal to sell. The kind of thing that hides in a 10-K.
- Receivables growing faster than salesAccounts receivable rose 41.1% while revenue rose 8.0% in the latest year — a gap that can signal looser credit terms or pulled-forward sales. Worth checking days-sales-outstanding.
- Heavy debt loadTotal debt of $1185.2M is 6.0× last year's operating cash flow — it would take years of cash flow to clear.
What growth is priced into ITGR stock?
At today's market cap of $3.13B, Integer Holdings Corporation is priced for free-cash-flow growth of about 13.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $105.12M from the FY ending 2025-12-31). For comparison, free cash flow actually grew -4.8%/yr over the last five fiscal years and revenue 11.5%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 17 years of Integer Holdings Corporation financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track ITGR in your portfolio →
Integer Holdings Corporation financial history by metric
Compare Integer Holdings Corporation with peers
About Integer Holdings Corporation
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Integer Holdings Corporation — frequently asked questions
What is Integer Holdings Corporation's revenue?
Integer Holdings Corporation (ITGR) reported revenue of $1.85B for fiscal year 2025, up 8.0% from the prior year, according to its SEC filings.
Is Integer Holdings Corporation profitable?
Yes. ITGR earned net income of $102.81M in fiscal 2025, a net margin of 5.5%.
What is ITGR's P/E ratio?
Integer Holdings Corporation trades at a price-to-earnings ratio of about 22.9 based on the latest data in our nightly-refreshed cache.
How fast is Integer Holdings Corporation growing?
ITGR's revenue grew at roughly 11.5% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Integer Holdings Corporation have?
As of fiscal year 2025, ITGR carried roughly $1.19B in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Integer Holdings Corporation's gross margin?
ITGR's gross margin was 27.0% in fiscal 2025 — gross profit of $500.39M on revenue of $1.85B.
What is Integer Holdings Corporation's market cap?
Integer Holdings Corporation (ITGR) has a market capitalization of about $3.13B, based on the latest data in our nightly-refreshed cache.
When does Integer Holdings Corporation's fiscal year end?
ITGR's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into ITGR stock?
At today's market cap of $3.13B, Integer Holdings Corporation is priced for free-cash-flow growth of about 13.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $105.12M from the FY ending 2025-12-31). For comparison, free cash flow actually grew -4.8%/yr over the last five fiscal years and revenue 11.5%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Integer Holdings Corporation's official SEC filings (10-K and 10-Q), covering 17 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.